Open — renewal application due September 30, 2026 at 5:00 PM local time of the applicant organization.Atlas Opportunity Score 84/100
RFA-DK-27-109
NIH NIDDK Single Source Competition: Continuation of the Cardiovascular Repository for Type 1 Diabetes (CaRe-T1D) Resource Center (U24 Clinical Trial Not Allowed) — RFA-DK-27-109
FundingNIDDK intends $2,000,000 in FY2027 for one award; application budgets are limited to $1,500,000 in direct costs per year. Maximum project period 5 years. No cost sharing required.
DeadlineSeptember 30, 2026 at 5:00 PM local time of the applicant organization.
Last verifiedSeptember 28, 2026
Required next actionApplicant preparation should include confirming University of Florida eligibility and active NIH/Grants.gov registrations, completing the RFA-DK-27-109 renewal package, and observing the September 30, 2026 5:00 PM local-time deadline.
Broad Eligibility
Single-source competition. Only the University of Florida, the current CaRe-T1D Resource Center funded under RFA-DK-21-010, is eligible to apply. Foreign organizations, non-U.S. components, and foreign components are not eligible/allowed as specified.
Atlas Analysis
Single-source U24 continuation for the CaRe-T1D Resource Center. Only the University of Florida is eligible to apply. NIDDK intends $2.0 million in FY2027 for one award; application budgets are limited to $1.5 million in direct costs per year, with a maximum project period of five years and no cost sharing required.
Funding Opportunity Number: RFA-DK-27-109
Issuing agency: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), with participating NIH cardiovascular research interests.
Application deadline: September 30, 2026 at 5:00 PM local time of the applicant organization.
Funding: NIDDK intends to commit $2,000,000 in FY2027 for one award. Application budgets are limited to $1,500,000 in direct costs per year. The maximum project period is five years. Cost sharing is not required.
Purpose: This U24 supports continuation of the CaRe-T1D Resource Center, including expansion of the human cardiovascular tissue biorepository, continued development of the data commons and artificial-intelligence tools, coordination of the CaRe-T1D investigative teams, and broader research-community access to consortium resources.
Eligibility restriction: Only the University of Florida, as the current CaRe-T1D Resource Center funded under RFA-DK-21-010, is eligible to apply. Foreign organizations, non-U.S. components, and foreign components are not eligible or allowed as specified in the NOFO.
Atlas assessment: Strong type 1 diabetes, cardiovascular, biorepository, and research-data relevance, but this is a single-source continuation. It is not an applicant-outreach opportunity and is not a Dr. Miltie direct-vendor path. Recommended posture: Restricted Single-Source / University of Florida Only / No Broad Routing.
Atlas score: 84/100 for healthcare relevance; pursuit eligibility is restricted.
Federal opportunity record
Source verificationOfficial government source · simpler.grants.govAtlas last verified this record September 28, 2026. Always use the funder's current application materials, amendments and portal instructions as the controlling source.View source and application materials ↗
